M&T Bank
HRTX icon

M&T Bank’s Heron Therapeutics HRTX Stock Holding History

M&T Bank’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-89,280
Closed -$134K – 1687
2023
Q1 		$134K Sell
89,280
-59,042
-40% -$148K ﹤0.01% 1535
2022
Q4 		$370K Buy
148,322
+87,790
+145% +$283K ﹤0.01% 1218
2022
Q3 		$256K Buy
60,532
+8,810
+17% +$34.5K ﹤0.01% 1335
2022
Q2 		$144K Buy
51,722
+26,870
+108% +$108K ﹤0.01% 1427
2022
Q1 		$142K Buy
24,852
+2,064
+9% +$15.1K ﹤0.01% 1415
2021
Q4 		$208K Buy
22,788
+1,243
+6% +$12.7K ﹤0.01% 1439
2021
Q3 		$230K Hold
21,545
– – ﹤0.01% 1370
2021
Q2 		$334K Hold
21,545
– – ﹤0.01% 1215
2021
Q1 		$349K Buy
21,545
+2,463
+13% +$43.9K ﹤0.01% 1173
2020
Q4 		$404K Hold
19,082
– – ﹤0.01% 1169
2020
Q3 		$282K Buy
19,082
+4,206
+28% +$65.6K ﹤0.01% 1267
2020
Q2 		$219K Buy
14,876
+2,135
+17% +$35.1K ﹤0.01% 1345
2020
Q1 		$150K Buy
12,741
+1,744
+16% +$32.8K ﹤0.01% 1371
2019
Q4 		$258K Sell
10,997
-14
-0.1% -$310 ﹤0.01% 1155
2019
Q3 		$204K Buy
+11,011
New +$203K ﹤0.01% 1422

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

M&T Bank's HRTX Position: Q2 2023 in Review

M&T Bank sold out of Heron Therapeutics (HRTX) in Q2 2023, closing a stake of 89,280 shares — an estimated $134K sold.

M&T Bank first reported a position in HRTX in Q3 2019 and held it in 15 quarters. The position peaked at $404K in Q4 2020. 149 funds tracked by Wall St. Rank hold HRTX as of Q2 2023.

  • M&T Bank reported no remaining Heron Therapeutics position as of Q2 2023 after selling out during the quarter.
  • M&T Bank sold 89,280 Heron Therapeutics shares in Q2 2023, an estimated $134K.
  • M&T Bank first reported a position in Heron Therapeutics in Q3 2019 and held it in 15 quarters.
  • M&T Bank's Heron Therapeutics position peaked at $404K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2023.

Based on M&T Bank's 13F filing for Q2 2023, filed 9 Aug 2023.